Eric P Dixon

Title: The Innovative Contributions of Eric P Dixon

Introduction

Eric P Dixon is a notable inventor based in Cary, NC (US), recognized for his significant contributions to the field of biotechnology. With a total of three patents to his name, Dixon has focused on developing methods and compositions that enhance the extraction and detection of nucleic acids and cancer biomarkers.

Latest Patents

Dixon's latest patents include innovative methods for extracting nucleic acids using ferric oxide particles. This method involves contacting biological samples with proteinase K and ferric oxide particles under acidic conditions, facilitating the binding of nucleic acids such as microRNAs (miRNAs). The process allows for the magnetic separation of the particles from the sample, followed by the release of nucleic acids using an alkaline elution buffer. Another significant patent involves the development of glycodelin monoclonal antibodies for the detection of ovarian cancer. This invention provides compositions and methods for diagnosing ovarian cancer, utilizing novel monoclonal antibodies that specifically bind to glycodelin, along with hybridoma cell lines that produce these antibodies.

Career Highlights

Throughout his career, Eric P Dixon has worked with prominent companies such as Tripath Imaging, Inc. and Becton Dickinson and Company Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Dixon has collaborated with notable colleagues, including Robert L Cheek and Timothy J Fischer, enhancing his research and development efforts in the biotechnology sector.

Conclusion

Eric P Dixon's innovative work in biotechnology, particularly in the extraction of nucleic acids and the detection of ovarian cancer, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical diagnostics and therapeutic methods.